Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study - Wikidata - wikimedia - TriplyDB

Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study

Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study

http://www.wikidata.org/entity/Q34129444

about

Inverse regulation of EGFR/HER1 and HER2-4 in normal and malignant human breast tissue.Poly (A)+ transcriptome assessment of ERBB2-induced alterations in breast cell lines.Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study.Expression of SATB1 and HER2 in breast cancer and the correlations with clinicopathologic characteristics.Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer Hormone-sensing cells require Wip1 for paracrine stimulation in normal and premalignant mammary epithelium Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study.Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status.Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor-Positive Breast Cancer.HER2 testing for breast carcinoma: recommendations for rapid diagnostic pathways in clinical practice.A Practical Approach to the Use of Immunohistochemistry in the Diagnosis and Management of Breast Disease

P2860

Q31134061-7032ADD0-8F45-4221-B2ED-52A14CE23835 Q33952142-ACCE155F-5D44-4632-BBBD-36A7BDF94596 Q34240305-55624F03-F437-42B5-B94D-0B416A1AEC03 Q35583904-55F65860-6024-430F-8FC0-75C6F5A02E6C Q36356432-FEA4C261-F86E-43AB-BABF-92D25A19B814 Q36903215-212FEEFE-2697-4AE3-A350-F8DD95693954 Q37559006-19B9C5FE-4859-435E-A6AB-639C968EE6AE Q39009607-9A239347-C93F-4CC9-A8D6-13C6155A56EF Q41811880-FBEDDB4D-E2A0-49A9-B0CE-FDCB004442F7 Q52841019-E03635A4-BF17-4D2E-AED3-925988FCE354 Q58423595-4D591404-33AB-45CC-9747-20EEB7784409

P2860

Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study

http://www.wikidata.org/entity/Q34129444

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Increased mortality in HER2 po ...... ncer: a population-based study

@ast

Increased mortality in HER2 po ...... ncer: a population-based study

@en

Increased mortality in HER2 po ...... ncer: a population-based study

@nl

type

label

Increased mortality in HER2 po ...... ncer: a population-based study

@ast

Increased mortality in HER2 po ...... ncer: a population-based study

@en

Increased mortality in HER2 po ...... ncer: a population-based study

@nl

prefLabel

Increased mortality in HER2 po ...... ncer: a population-based study

@ast

Increased mortality in HER2 po ...... ncer: a population-based study

@en

Increased mortality in HER2 po ...... ncer: a population-based study

@nl

P1433

Q34129444-6F2C8DEC-D5D5-4B51-9C65-3955CA721206

P1476

Q34129444-BC9B91E1-E6C1-443B-BF89-F960D0A38A6E

P2093

Q34129444-278008F4-2DB9-4BC2-B276-7CA4E417C32A

Q34129444-46B9111B-EC98-4704-9EF4-3FDF11B65C33

Q34129444-4983BFF7-3591-4C9D-B6C8-EBE60D8401A0

Q34129444-5B3223FA-2E49-4EAB-B445-3C1907F8F483

Q34129444-72261640-AB17-41C7-8FCE-6D122C5F911B

Q34129444-8F81EBDC-874A-488F-AFDE-2465AC62C501

Q34129444-EC6A782E-1B8F-4C00-BE8B-B90D0520BCCA

P2860

Q34129444-01712C91-FE58-405F-BD0F-6369E311EFC8

Q34129444-09A6614A-BDA8-412B-AC49-C6213D38DD2B

Q34129444-121CBD10-02E9-4F9C-932E-790585804062

Q34129444-14DC839D-D6F1-4D74-89C2-FDD07FF62796

Q34129444-1AB39E89-1375-4DB1-9484-AE49E9A02EF9

Q34129444-21BCE454-8606-41B2-94DB-BD0E242B9C74

Q34129444-2456A3C4-C939-44DB-A932-9557FB4EE33A

Q34129444-2C9D2C06-09DB-4FAF-867C-F23C29F2E417

Q34129444-40DE20D2-BB48-4BC9-8006-03A8246E4164

Q34129444-428D7264-FF10-4660-9DC5-B8182D9EDC56

P2888

Q34129444-20312DA1-BF88-4AA4-9C92-29FF2F502182

P304

Q34129444-DCC874E7-E9B5-4072-B51B-F682E72F276F

P31

Q34129444-B4792C5C-7139-457C-93A9-83DF6EE86DD5

P356

Q34129444-CC2F0089-2A14-42A5-ADBC-8922355C6DE5

P407

Q34129444-13AF0B1A-B580-41DC-B563-702395536A92

P433

Q34129444-68541318-1CAC-43A0-8EF2-4D1AB82F36A0

P478

Q34129444-7DCEFE85-0B2C-43A3-9441-CD764921ABB6

P50

Q34129444-1BD93042-7904-417F-BD91-14BE74676E48

Q34129444-F66A6BCE-CEAD-4E13-8D35-0030D00DF036

P577

Q34129444-C4B90499-7AF2-4EF3-891C-16A7A20BF6B1

P5875

Q34129444-B7CCA47A-7A07-4060-BD16-47E59D9C7957

P6179

Q34129444-66A3D0AA-E741-4D49-918A-EA829ED8E368

P698

Q34129444-C8A50124-9B8D-4F94-8EBB-3C3457DEA2E5

P932

Q34129444-6D3306E2-3636-4C90-82A2-2F6377C4A002

P356

P1433

British Journal of Cancer

P1476

Increased mortality in HER2 po ...... ncer: a population-based study

@en

P2093

A Ashfield

http://www.w3.org/2001/XMLSchema#string

A M Thompson

http://www.w3.org/2001/XMLSchema#string

D J A Adamson

http://www.w3.org/2001/XMLSchema#string

J A Dewar

http://www.w3.org/2001/XMLSchema#string

L B Jordan

http://www.w3.org/2001/XMLSchema#string

L Baker

http://www.w3.org/2001/XMLSchema#string

S Chatterjee

http://www.w3.org/2001/XMLSchema#string

P2860

High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

A data model to predict HER2 status in breast cancer based on the clinical and pathologic profiles of a large patient population at a single institution.

Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years.

The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis

P2888

P304

475-481

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6605799

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Philip R Quinlan

P577

2010-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45389525

http://www.w3.org/2001/XMLSchema#string

P6179

1006348926

http://www.w3.org/2001/XMLSchema#string

P698

20664587

http://www.w3.org/2001/XMLSchema#string

P932

2939790

http://www.w3.org/2001/XMLSchema#string